Highlight text to provide feedback
| Disease found: | Acquired Lipodystrophy |
| Current as of: | October 8, 2024 |
| Disease Overview: | Complete (generalized) or partial loss of adipose tissue |
| Signs and Symptoms: | Varying symptoms, severity, and prognosis across different subtypes and individuals [more info] |
| Diagnosis: | Characteristic symptomology; presence of panniculitis is supportive of AGL diagnosis [more info] |
| Treatment: | Symptom specific; diet modification; Metreleptin (leptin analog) [more info] |
| Clinical Management: | High carbohydrate, low-fat diet [more info] |
| Referral: | Via patient organizations [more info]. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health. |
| Clinical Trials: | For Type I DM patients with acquired lipodystrophy, 1 recruiting [more info] |